本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Crescent Biopharma Inc

19.84
+0.43002.22%
成交量:16.30萬
成交額:325.92萬
市值:7.37億
市盈率:-2.68
高:20.40
開:19.50
低:19.42
收:19.41
52周最高:27.41
52周最低:8.72
股本:3,714.39萬
流通股本:1,595.35萬
量比:0.53
換手率:1.02%
股息:- -
股息率:- -
每股收益(TTM):-7.4105
每股收益(LYR):-12.8150
淨資產收益率:-160.75%
總資產收益率:-69.15%
市淨率:10.16
市盈率(LYR):-1.55

資料載入中...

2019/07/24

超過5%披露

General statement of acquisition of beneficial ownership
2019/07/23

超過5%披露

General statement of acquisition of beneficial ownership
2019/07/15

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/07/10

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/07/02

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/07/02

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/07/02

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/07/02

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/06/17

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/06/17

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/06/17

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/06/17

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/06/17

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/06/17

重要事件披露

Current report, item 5.07
2019/05/02

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/05/02

重要事件披露

Current report, items 2.02 and 9.01
2019/04/29

[修訂]年度報告

[Amend] Annual report [Section 13 and 15(d), not S-K Item 405]
2019/02/11

SEC問詢函

[Cover]Correspondence
2018/02/14

超過5%披露

2018/02/09

超過5%披露

催化劑生物科學有限公司